$CVX's 2Q15 effective tax rate rose to 55% from 37% in 2Q14. The increase in tax rate primarily resulted from the effects of jurisdictional mix, the sale of interest in Caltex Australia Ltd, valuation allowances recognized on deferred tax assets and foreign currency remeasurement, partially offset by the effects of equity earnings.
$EQIX agreed for the purchase of ICT-Center AG, Zurich's data center operating business in Zurich, Switzerland for less than $5MM. The agreement was signed on Feb. 1, 2017 and the acquisition is expected to close sometime in early April 2017.
$TGT is currently operating in a challenging environment where many
retailers are closing stores, exiting markets and cutting costs. This
contraction will create opportunities for $TGT to pick up market share over the
long-term but aggressive promotional activity will create pressure on the
business in the near term.
$PRGO agreed to divest Tysabri royalty stream. Royalty Pharma will buy all of $PRGO's rights to receive Tysabri royalty payments from and after Jan. 1, 2017, which $PRGO has under agreement with $BIIB. Tysabri is FDA approved treatment for multiple sclerosis. $PRGO acquired Tysabri royalty stream rights through 2013 acquisition of Elan Corp. plc.